October 10, 2016
Investors flee as firm scraps RNA-interference drug candidate
news@nature.com - Fetched: October 10th, 2016, 3:00pm UTC
Struggling RNAi field faces another blow as its first treatments near the clinic.
Nature News doi: 10.1038/nature.2016.20769